PSYCHOPHARMACEUTICAL THERAPY AND SUPPORTIVE PSYCHOTHERAPY FOR COVID-19 PATIENTS WITH DEPRESSION

ABSTRACT: A depressive disorder is a disorder characterized by the presence of major symptoms of a depressive mood, loss of interest and excitement, reduced energy leading to increased fatigue and reduced activity, namely reduced concentration and attention, reduced self-esteem and self-confidence, ideas about guilt and uselessness, gloomy and pessimistic outlook, thoughts or actions of self-harm or suicide, disturbed sleep, and decreased appetite for at least 2 weeks. In this case report, a 24 years old female complaints of feeling sad after being diagnosed with COVID-19. Patients had a sad face, depressive affect, become less interested in their usual activities (e.g. exercising in the morning), easily tired. Sometimes patient didn’t want to eat, had disturbed sleep, felt guilty of why she caught COVID-19 and thought about the fate of her family, lacks self-confidence and trust to those who cared for her, is irritable and makes it difficult for medical workers to provide treatment, overreacting to the officer who told her the results of the examination, had wanted to move hospital without appropriate medical indication. These have happened for more than 2 weeks, thus disrupting the patient’s activities and health in general. Patients were given pharmacological (sertraline and clobazam) and non-pharmacological (supportive psychotherapy and cognitive behavior therapy) therapy. KEYWORDS Major Depression Without Psychotic Symptoms, Supportive Psychotherapy, Cognitive Behavior Therapy